8-KLeadership ChangesExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Executive Changes (May 22, 2025)

Filed May 22, 2025For Securities:TMO

Summary

Thermo Fisher Scientific Inc. announced a significant long-term incentive award to its Chairman, President, and CEO, Marc N. Casper. The company's Board of Directors approved a 5-year performance-based restricted stock unit (RSU) award with a target grant date fair value of approximately $60 million. This award is designed to incentivize continued leadership through at least May 2030 and to drive substantial shareholder returns, specifically through outperformance in Total Shareholder Return (TSR) relative to the S&P 500. The Board's decision was based on a thorough review, highlighting Mr. Casper's extensive track record of value creation, including quadrupling annual revenue to $43 billion and achieving over 800% TSR during his tenure, significantly outperforming the S&P 500 Equal Weight Index. Investor feedback also underscored the importance of his continued leadership for long-term value creation. The award structure, with a 5-year cliff vesting and an additional deferred share delivery for up to 10 years post-grant, aims to ensure sustained alignment with shareholder interests.

Key Highlights

  • 1CEO Marc N. Casper granted a 5-year performance-based RSU award with a target fair value of $60 million to ensure leadership continuity through at least May 2030.
  • 2The award is directly tied to Thermo Fisher's Total Shareholder Return (TSR) performance relative to the S&P 500 over a performance period ending December 31, 2029.
  • 3Payouts are tiered: target achievement at the 50th percentile of S&P 500 TSR, 125% of target for 75th percentile or higher, and a 50% reduction for performance below the 25th percentile.
  • 4Shares earned will vest on May 21, 2030, with actual delivery deferred in equal tranches on the 8th, 9th, and 10th anniversaries of the grant date to promote long-term alignment.
  • 5The Board cited Mr. Casper's proven track record, including revenue growth from $10 billion to $43 billion and over 800% TSR during his tenure, as key reasons for the award.
  • 6Investor feedback emphasizing the importance of executive leadership continuity for long-term shareholder value was a significant factor in the decision.
  • 7The performance-based RSU grant is non-recurring and distinct from Mr. Casper's regular annual compensation.

Frequently Asked Questions

The primary purpose of the award is to secure Mr. Casper's continued leadership through at least May 2030 and to strongly incentivize him to drive substantial long-term shareholder returns, specifically through outperforming the S&P 500 in Total Shareholder Return (TSR).

The award is performance-based and contingent on Thermo Fisher's TSR relative to the S&P 500 over a specific performance period. Achievement is tiered, with different payout percentages based on where the company's TSR ranks within the S&P 500 peer group.

The performance-based restricted stock units will cliff vest on May 21, 2030, provided Mr. Casper remains CEO or Executive Chairman. However, the delivery of any earned shares is further deferred, with equal tranches delivered on the 8th, 9th, and 10th anniversaries following the grant date, ensuring a long-term alignment with shareholders.

No, this performance-based restricted stock unit grant is explicitly stated as non-recurring and is not part of Mr. Casper's regular annual compensation. It is a special long-term incentive award.